Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
TipRanks on MSN
Roche Exercises Option with Recursion Pharmaceuticals
An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback